Status:
COMPLETED
The Effect of Mealworm Protein Ingestion on Muscle Protein Synthesis After Running Exercise in Humans
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Muscle Protein Synthesis
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Rationale: Consumption of sufficient dietary protein is fundamental to skeletal muscle mass maintenance and overall health. Conventional animal-based protein sources such as meat, poultry, fish, eggs,...
Detailed Description
To assess whether volunteers are eligible to participate in this study, we will invite them to the University for a screening visit. At the start of the screening session, the entire experimental tria...
Eligibility Criteria
Inclusion
- Age 18 - 35 y
- BMI 18.5 - 30 kg/m2
- Having given informed consent
Exclusion
- Participating in a structured (progressive) exercise program
- Smoking regularly
- Allergy to house dust mites or crustaceans
- Diagnosed GI tract disorders or diseases
- Diagnosed musculoskeletal disorders
- Diagnosed metabolic disorders (e.g. diabetes)
- Cardiovascular disease
- Hypertension (blood pressure above 140/90 mmHg)
- Donated blood 3 months prior to test day
- Pregnant
- Amenorrhea
- Using third generation oral contraceptives
- Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories).
- Chronic use of gastric acid suppressing medication
- Chronic use of anti-coagulants
- Recent (\<1 year) participation in amino acid tracer (L-\[ring-13C6\]-phenylalanine and L-\[3,5-2H2\]-tyrosine studies
Key Trial Info
Start Date :
June 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05353595
Start Date
June 3 2022
End Date
September 21 2023
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Centre+
Maastricht, Limburg, Netherlands, 6229ER